By Arun AgrahriLast reviewed 1 timecoded source
Short answer
Lower than most labs flag as normal. Studies Precis has read agree that heart risk keeps rising as ApoB climbs. Targets on tape run from under 90, ideally under 70 mg/dL, to a ceiling of 60. One study in high blood pressure found the lowest death risk near 100 mg/dL.
Lowering ApoB lowers the risk of heart disease.
The verdict on ApoB overall. 2 sources: 2 positive
positive partly neutral negative Each researcher and each study counts once per claim, however often they come up.
A good ApoB level is lower than what standard labs call normal.
7 sources: 6 positive, 1 negative.
Researchers say
2 positive
Dr. Mark Hyman, 2 mentions on this claim
Positive Video
on Rangan Chatterjee's channel, at 1:20:59 · positive
“it is far more predictive than LDL cholesterol which is what most doctors look at and the level you should have is under 90 but ideally probably under 70”
on The Dr. Hyman Show, at 1:09:25 · positive
“conventional medicine is 20 to 90 H the risk increases most over 120 but probably the optimal range is 40 to 70”
Peter Attia, 3 mentions on this claim
Positive Video
on The Drive, at 02:38 · positive
“pharmacologically lower apob to somewhere in the 20 to 30 milligram per deciliter range for everybody in the population”
on The Drive, at 03:25 · positive
“i would view an apo b ceiling of 60 as the limit and that's probably at about the fifth percentile”
on Huberman Lab, at 51:22 · partly
“then you want apob as low as possible”
Studies show
4 positive, 1 negative
5 papers we read
Controlled trial, Circulation, 2016, PMID 27777279
Positive Study
Read the paper on PubMed →Similar associations were observed with non–high-density lipoprotein cholesterol and apolipoprotein B achieved levels, percentage reductions, and MACE.
Controlled trial, Circulation, 2022, PMID 35770629
Positive Study
Read the paper on PubMed →In each achieved LDL-C stratum, treatment benefit increased in progressively lower achieved apoB strata.
Other primary study, JAMA Netw Open, 2024, PMID 38241044
Positive Study
Read the paper on PubMed →We observed monotonically increasing associations of genetically predicted apoB with CAD, all-cause mortality, and CVD mortality ( Figure 3 and eFigure 1 in Supplement 1 ).
Other primary study, Lipids Health Dis, 2026, PMID 41535885
Positive Study
Read the paper on PubMed →Restricted cubic spline analyses indicated an approximately linear increase in risk with a higher apoB level for ASCVD and MACE (ASCVD: overall P < 0.001, P for nonlinearity = 0.156, Fig.
Other primary study, BMC Cardiovasc Disord, 2024, PMID 38789961
Negative Study
Read the paper on PubMed →There was a U-shaped relationship between serum ApoB levels and the risk of ACM and CVM, with the lowest risk around 100 mg/dL.
Dr. Mark Hyman Video · positive · 2 mentions
on Rangan Chatterjee's channel, at 1:20:59 · positive · Opinion
“it is far more predictive than LDL cholesterol which is what most doctors look at and the level you should have is under 90 but ideally probably under 70”
on The Dr. Hyman Show, at 1:09:25 · positive · Opinion
“conventional medicine is 20 to 90 H the risk increases most over 120 but probably the optimal range is 40 to 70”
Peter Attia Video · positive · 3 mentions
on The Drive, at 02:38 · positive · Opinion
“pharmacologically lower apob to somewhere in the 20 to 30 milligram per deciliter range for everybody in the population”
on The Drive, at 03:25 · positive · Opinion
“i would view an apo b ceiling of 60 as the limit and that's probably at about the fifth percentile”
on Huberman Lab, at 51:22 · partly · Opinion
“then you want apob as low as possible”
Controlled trial, Circulation, 2016, PMID 27777279 Study · positive
Similar associations were observed with non–high-density lipoprotein cholesterol and apolipoprotein B achieved levels, percentage reductions, and MACE.
Controlled trial, Circulation, 2022, PMID 35770629 Study · positive
In each achieved LDL-C stratum, treatment benefit increased in progressively lower achieved apoB strata.
Other primary study, JAMA Netw Open, 2024, PMID 38241044 Study · positive
We observed monotonically increasing associations of genetically predicted apoB with CAD, all-cause mortality, and CVD mortality ( Figure 3 and eFigure 1 in Supplement 1 ).
Other primary study, Lipids Health Dis, 2026, PMID 41535885 Study · positive
Restricted cubic spline analyses indicated an approximately linear increase in risk with a higher apoB level for ASCVD and MACE (ASCVD: overall P < 0.001, P for nonlinearity = 0.156, Fig.
Other primary study, BMC Cardiovasc Disord, 2024, PMID 38789961 Study · negative
There was a U-shaped relationship between serum ApoB levels and the risk of ACM and CVM, with the lowest risk around 100 mg/dL.
A good ApoB level is lower than what standard labs call normal.
Researchers
Dr. Mark Hyman, 2 mentions on this claim
Positive Video
on Rangan Chatterjee's channel, at 1:20:59 · positive
“it is far more predictive than LDL cholesterol which is what most doctors look at and the level you should have is under 90 but ideally probably under 70”
on The Dr. Hyman Show, at 1:09:25 · positive
“conventional medicine is 20 to 90 H the risk increases most over 120 but probably the optimal range is 40 to 70”
Peter Attia, 3 mentions on this claim
Positive Video
on The Drive, at 02:38 · positive
“pharmacologically lower apob to somewhere in the 20 to 30 milligram per deciliter range for everybody in the population”
on The Drive, at 03:25 · positive
“i would view an apo b ceiling of 60 as the limit and that's probably at about the fifth percentile”
on Huberman Lab, at 51:22 · partly
“then you want apob as low as possible”
Studies
Controlled trial, Circulation, 2016, PMID 27777279
Positive Study
Read the paper on PubMed →Similar associations were observed with non–high-density lipoprotein cholesterol and apolipoprotein B achieved levels, percentage reductions, and MACE.
Controlled trial, Circulation, 2022, PMID 35770629
Positive Study
Read the paper on PubMed →In each achieved LDL-C stratum, treatment benefit increased in progressively lower achieved apoB strata.
Other primary study, JAMA Netw Open, 2024, PMID 38241044
Positive Study
Read the paper on PubMed →We observed monotonically increasing associations of genetically predicted apoB with CAD, all-cause mortality, and CVD mortality ( Figure 3 and eFigure 1 in Supplement 1 ).
Other primary study, Lipids Health Dis, 2026, PMID 41535885
Positive Study
Read the paper on PubMed →Restricted cubic spline analyses indicated an approximately linear increase in risk with a higher apoB level for ASCVD and MACE (ASCVD: overall P < 0.001, P for nonlinearity = 0.156, Fig.
Other primary study, BMC Cardiovasc Disord, 2024, PMID 38789961
Negative Study
Read the paper on PubMed →There was a U-shaped relationship between serum ApoB levels and the risk of ACM and CVM, with the lowest risk around 100 mg/dL.
Precis is not affiliated with or endorsed by YouTube or by any researcher, show or publisher we quote. We take no sponsorship, ad or affiliate money, and every verdict is our own review of what was said. How we stay independent
A good ApoB level is lower than the lab's normal flag, by the studies Precis has read. There is no one universal number, but the direction is clear. ApoB counts the particles that build plaque (LDL, VLDL and Lp(a)) instead of the cholesterol they carry. That gives a fuller picture of heart risk than LDL-C.
Seven credited sources count: five studies and two researchers on tape. Six back the claim and one does not. A genetic study, using Mendelian randomization (a method that uses inherited gene variants to test cause), found that risk of coronary artery disease and death kept climbing as ApoB rose.
A UK Biobank study of people with type 2 diabetes found heart risk rising in a roughly straight line with ApoB. A pooled analysis of trials of the drug alirocumab linked lower achieved ApoB to fewer major heart events. After a heart attack or unstable angina, the drug's benefit grew as achieved ApoB fell.
Peter Attia, on his own show, treats an ApoB of 60 as the ceiling, which he places at about the fifth percentile. He would go further and lower ApoB with drugs to 20 to 30 mg/dL for everybody. He points to children, who run about 20-40 mg/dL, as the benchmark, and works to about 60 mg/dL for people in their late 30s and early 40s.
Mark Hyman, a guest on Rangan Chatterjee's show, says under 90 but ideally under 70. On his own show, he puts the likely optimal range at 40 to 70.
One study pushes back. In people with high blood pressure, the link between ApoB and death was U-shaped, with the lowest risk around 100 mg/dL. Few studies Precis has read set a lab's normal range against outcomes directly. The case rests on risk rising inside that range. Another 12 studies on this claim wait for a full read before they count.
ApoB is often missing from a basic cholesterol panel, so ask for it with advanced lipid testing. A normal LDL can hide a high particle count. Hitting a low target usually takes diet plus medication under a doctor's care, such as statins, ezetimibe, bempedoic acid or PCSK9 inhibitors. Your target, and whether to add a drug, is your physician's call.
Precis membership
The answer above is the whole answer: the verdict, every counted mention, where the sources disagree, and the receipt behind each one. Nothing on this page is held back.
A free account adds
Pro adds
Full ApoB evidence report
The verdict on every claim, and where the sources disagree